CIM
BLUE

CIM Investment Management’s bluebird bio BLUE Stock Holding History

CIM Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-135
Closed -$298K – 337
2018
Q1 		$298K Buy
+135
New +$343K 0.1% 266
2017
Q4 		– Sell
-168
Closed -$300K – 327
2017
Q3 		$300K Buy
+168
New +$235K 0.11% 252
2015
Q2 		– Sell
-206
Closed -$322K – 260
2015
Q1 		$322K Buy
+206
New +$272K 0.14% 157

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIM Investment Management's BLUE Position: Q2 2018 in Review

CIM Investment Management sold out of bluebird bio (BLUE) in Q2 2018, closing a stake of 135 shares — an estimated $298K sold.

CIM Investment Management first reported a position in BLUE in Q1 2015 and held it in 3 quarters. The position peaked at $322K in Q1 2015. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

  • CIM Investment Management reported no remaining bluebird bio position as of Q2 2018 after selling out during the quarter.
  • CIM Investment Management sold 135 bluebird bio shares in Q2 2018, an estimated $298K.
  • CIM Investment Management first reported a position in bluebird bio in Q1 2015 and held it in 3 quarters.
  • CIM Investment Management's bluebird bio position peaked at $322K in Q1 2015.
  • 307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on CIM Investment Management's 13F filing for Q2 2018, filed 7 Aug 2018.